Cougar Biotechnology Announces Presentation at Rodman & Renshaw Techvest 7th Annual Healthcare Conference.LOS ANGELES -- Cougar cougar: see puma. cougar or puma or mountain lion or panther Species (Puma concolor) of large, graceful cat that lives in a wide variety of habitats in the Americas, from southern Alaska to Patagonia. Biotechnology, Inc., a privately held biotechnology company, today announced that Alan H. Auerbach, Chief Executive Officer and President of Cougar, will present at the Rodman & Renshaw Techvest 7th Annual Healthcare Conference on Wednesday, November 9th at 8:20 AM EST EST electroshock therapy. EST abbr. electroshock therapy at the New York Palace
New York, Middle Atlantic state of the United States. It is bordered by Vermont, Massachusetts, Connecticut, and the Atlantic Ocean (E), New Jersey and Pennsylvania (S), Lakes Erie and Ontario and the Canadian province of , NY. Mr. Auerbach will provide a company overview and update on the status of Cougar's current clinical development programs. A live webcast of the presentation can be accessed on the Company's website at www.cougarbiotechnology.com. The presentation will also be archived shortly after the live event and available online for 90 days following the conference. About Cougar Biotechnology Cougar Biotechnology, Inc. is a Los Angeles-based private biotechnology company established to in-license and develop clinical stage drugs, with a specific focus on the field of oncology. Cougar's oncology portfolio includes CB7630, which has completed Phase I clinical trials in prostate cancer prostate cancer, cancer originating in the prostate gland. Prostate cancer is the leading malignancy in men in the United States and is second only to lung cancer as a cause of cancer death in men. , CB3304, which is currently being tested in a Phase I trial in non-Hodgkin's lymphoma and CB1089, which has been clinically tested in a number of solid tumor types. Further information about Cougar Biotechnology can be found at www.cougarbiotechnology.com. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion